Acute leukemias progress rapidly without treatment.
急性白血病发病急骤无法治疗。
Methods MTT, CFU-L and indirect immune fluorescence were used in 18 patients with acute leukemias.
方法应用MTT、CFU - L及间接免疫荧光法对18例急性白血病进行观察。
Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
相对于急性白血病，慢性淋巴细胞白血病和慢性粒细胞性白血病通常进展缓慢。
Objective to observe the curative effect of experiential treatments to the infection after chemotherapy in acute leukemias.
目的观察急性白血病病人联合化疗后粒细胞缺乏发热时抗生素经验性治疗的疗效。
It is suggested that acute leukemias associated with CD7 antigen may be come from different early t cells and myeloid cells.
上述结果提示，伴有CD 7抗原表达的急性白血病实际上是T、粒等多种细胞来源的白血病。
Objective To explore the value of direct smear and ABC-AP staining method in immunophenotyping diagnosis of acute leukemias (al).
目的探讨直接涂片abc- AP染色在急性白血病免疫分型诊断中的价值。
Objective: to investigate the expression of promotive and inhibitory apoptotic genes, the DNA content of the cells and their interrelationship in acute leukemias.
目的：研究急性白血病促、抑凋亡基因表达、白血病细胞DNA含量及三指标间相关性。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
Lymphoproliferative malignancies include lymphomas and acute lymphoblastic and chronic lymphocytic leukemias.
恶性淋巴增生包括淋巴瘤、急性淋巴细胞白血病和慢性淋巴细胞白血病。
Lymphoproliferative malignancies include lymphomas and acute lymphoblastic and chronic lymphocytic leukemias.
恶性淋巴增生包括淋巴瘤、急性淋巴细胞白血病和慢性淋巴细胞白血病。
应用推荐